Comment rechercher la NASH chez les patients porteurs d’un foie gras non alcoolique (notice n° 262660)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02587cam a2200373 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112074510.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Béorchia, Sylvain |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Comment rechercher la NASH chez les patients porteurs d’un foie gras non alcoolique |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2011.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 3 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | La courbe ascendante de l’obésité dans la population occidentale a fait émerger une nouvelle maladie hépatique, la stéatohépatite non alcoolique ou NASH des anglo-saxons. Cette brève revue rapporte les éléments les plus significatifs concernant le diagnostic et les grands principes de son traitement. La biologie, les marqueurs biologiques de fibrose hépatique, l’imagerie et le Fibroscan® offrent de nouvelles perspectives pour différencier la banale stéatose de la stéatohépatite dont l’évolution fibrosante est rappelée. La ponction biopsie hépatique reste encore incontournable lorsqu’il existe une discordance entre les tests et en cas de forme avancée. Elle permet alors d’intensifier le traitement médical jouant sur l’insulino-résistance et les agents antifibrosants. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The rising curve of obesity in the Western population has induced a new liver disease, nonalcoholic steatohepatitis. This short review reports the most significant elements regarding its diagnosis and the main principles of the treatment. Biology, biomarkers of hepatic fibrosis, imaging and Fibroscan® have opened new perspectives to differentiate common steatosis from steatohepatitis potentially contributing to the development of fibrosis. Liver puncture biopsy remains inevitable if a discrepancy arises between the tests and in the case of an advanced stage. It thus allows for intensifying the medical treatment combining insulin-sensitizing agents and antifibrotic therapy. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Ponction biopsie hépatique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Fibroscan® |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | NASH |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Insulino-résistance |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Stéatose |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Marqueurs biologiques de la fibrose hépatique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Stéatohépatite |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Steatohepatitis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Fibroscan® |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Steatosis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | NASH |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Biomarkers of hepatic fibrosis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Insulin resistance |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Liver puncture biopsy |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Delasalle, Patrick |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bonny, Corinne |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hanslik, Bertrand |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hegel | 1 | 1 | 2011-01-01 | p. 2-10 | 2269-0530 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-hegel-2011-1-page-2?lang=fr">https://shs.cairn.info/revue-hegel-2011-1-page-2?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux